FDA Drug Recalls

Recalls / Class II

Class IID-0611-2022

Product

Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle, Dist. by Target Corp., Mpls., MN 55403. NDC 11673-935-10

Affected lot / code info
Batch: 1BK0912, Exp 12/31/2022; 1FK1251, Exp 02/28/2023

Why it was recalled

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Recalling firm

Firm
Perrigo Company PLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, Allegan, Michigan 49010-9070

Distribution

Quantity
89,208 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-10-26
FDA classified
2022-02-23
Posted by FDA
2022-03-02
Terminated
2023-09-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0611-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls